Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Begins Cuts With Manufacturing, More Cost Reductions To Follow

This article was originally published in The Pink Sheet Daily

Executive Summary

The company suggests future restructuring efforts could address R&D, marketing and sales after unveiling the first phase of its restructuring initiative.

You may also be interested in...



Merck Aims To Duplicate Januvia Launch Success In 2007

Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.

Merck Aims To Duplicate Januvia Launch Success In 2007

Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.

Merck Cost Cuts Round Two: Sales & Marketing Take A Hit

Company announces additional $1 bil. in savings, mostly from reductions in marketing and administrative costs.

Related Content

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel